PHILADELPHIA, Pennsylvania -
- Highly Respected Text Addresses New Strains of the Swine (H1N1) and Avian Influenza Viruses.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th Edition. Marking 30 years since its initial publication, it remains the most respected reference source of its kind, and maintains its relevance in the face of the emergence of newly recognized infectious diseases, including new strains of the swine (H1N1) and avian influenza viruses.
Edited by renowned experts Gerald L. Mandell, MD, MACP; John E. Bennett, MD, MACP; and Raphael Dolin, MD, Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases provides comprehensive, global guidance on diagnosing and treating the full spectrum of infectious diseases. Contributions from hundreds of the world’s most noted authorities provide fresh perspectives and expanded global insights.
Since the first edition was published in 1979, much has changed. “Given that Infectious Diseases is an amazingly dynamic specialty, when you compare the 7th edition to the very first edition, there are many more chapters. When you compare the 7th edition with the 6th edition, there are extensive revisions even to the chapters that have appeared previously,” says Gerald Mandell, MD, the founding editor. “For example, most chapters were written in 2009, and are thus very current. There are a number of chapters related to infection control in hospitals, antibiotic resistance in travel medicine, infections in immunocompromised patients, infections from exotic pets, and a lot of new information about HIV/AIDS. There is also markedly expanded coverage of bio-terrorism agents, which infectious disease specialists need to know about.”
Users of this 7th edition can access the full text online with regular updates, downloadable image library, drug database, and more at Elsevier’s Expert Consult (www.expertconsultbook.com/) web site. “The knowledge and experience of the world’s authorities, with careful review by the three editors, make the information a lot more valuable than just searching for facts online,” says Dr. Mandell.
Notes to Editors:
Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th Edition - Expert Consult Premium Edition - Enhanced Online Features and Print (ISBN: 978-0-4430-6839-3) is 4320 pages in length and contains approximately 1100 illustrations. The lead editor, Gerald L. Mandell, MD, MACP, is Professor of Medicine Emeritus, Owen R. Cheatham Professor of the Sciences Emeritus, Division of Infectious Diseases, University of Virginia Health Sciences Center, Charlottesville, VA.
Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th Edition is available at www.us.elsevierhealth.com. Dr. Mandell may be reached for interviews by contacting Tom Reller at T.Reller@Elsevier.com. For review copies, please contact Courtney Ingram at c.ingram@elsevier.com or at+1-215-239-3462.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai’s Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact: Tom Reller Elsevier Tel: +1-212-462-1912 E-mail: t.reller@elsevier.com
Source: Elsevier
Media Contact: Tom Reller, Elsevier, Tel: +1-212-462-1912, E-mail: t.reller at elsevier.com
Related Press Releases
Spine Surgery Worldwide Products and TechnologiesSeptember 29th, 2009 Spine Surgery Worldwide 2008-2017: Products, Technologies, Markets and Opportunities Report ( http://www.bharatbook.com/Market-Research-Reports/Spine-Surgery-Worldwide-2008-2017-Products-Technologies-Markets-and-Opportunities.html ) details the complete range of products and technologies in spine surgery, including the surgical management of spine disorders, diseases and trauma, with treatments including use of grafts, demineralized bone, fusion, stabilization, disc replacement, nucleus replacement, vertebroplasty, kyphoplasty, imaging, minimally invasive surgical technologies, energy-based therapies and biologics. The report details current clinical and technology developments in the huge and rapidly growing spine surgery technologies worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.
ART + AUCTION Is Celebrating Its 30th Anniversary 1979 - 2009September 3rd, 2009 NEW YORK -
- The Magazine Looks Back at the Art Market's Highs and Lows, from Keith Haring's Pop Shop to Larry Salander's Financial Shenanigans
ART + AUCTION, the leading global art-investment magazine, published by Louise Blouin Media, is celebrating its 30th anniversary. Over the past 30 years, ART + AUCTION has covered the shifting fortunes of the art world and its inhabitants.
Buongiorno Preliminary Results for H1 2009August 3rd, 2009 MILAN -
- EBITDA of Euro 18.6 Million, up 14% Compared to H1 2008, Thanks to the Growth of the Most Profitable Business Segments and the Decrease of Fixed Costs. - EBITDA of Q2 2009: Euro 10.2 Million up 25% Compared to Q2 2008.
CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical ResearchAugust 3rd, 2009 EINDHOVEN, The Netherlands - With today's final approval of a research project into prostate cancer, the Dutch CTMM (Center for Translational Molecular Medicine) today announced the successful completion of 265 million euro funding for translational (bench-to-bedside) medical research, making CTMM one of the largest public-private partnerships in the world. This pivotal point in the organisation's development firmly positions the Netherlands as one of the world's leading destinations for translational biomedical research.
The 13th Edition of the World's Best Sommelier CompetitionJune 18th, 2009 PARIS - Santiago, Chile, April 2010
With great panache, Moet & Chandon endorses this 13th Edition in celebration of its longstanding relationship with sommeliers the world over - a commitment of both the heart and the mind. Moet & Chandon itself has long been established as the leader wherever excellence reigns all across the globe.
Invitation: PROSTVAC(TM) Wrap upMay 26th, 2009 KVISTGAARD, Denmark - Following the presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine candidate for the treatment of advanced prostate cancer, Bavarian Nordic will be hosting a Q&A session at the ASCO Annual Meeting. Time: Sunday, May 31st 2009 from 09 AM EDT to 10 AM EDT.
The Institut Pasteur and Mérieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious DiseasesMay 17th, 2009 PARIS - The Institut Pasteur and Mérieux Alliance have signed a letter of intent for a long-term research partnership. The Institut Pasteur and Mérieux Alliance (which comprises the companies: bioMérieux, Transgene, Shantha Biotechnics, ABL and Silliker) would like to pool their resources and efforts to fight infectious diseases through major research projects, spanning the following fields:
- Clinical diagnostics and theranostics (in partnership with bioMérieux and Transgene) - Food safety and microbiological control, nutrition, health and environment (with bioMérieux and Silliker) - Immunotherapy (with Transgene and Shantha Biotechnics)
The research projects under consideration must focus on major pathologies calling upon expertise in the fields of virology, bacteriology and immunology.
5th Anniversary of Enlargement on TV5 MondeApril 27th, 2009 BRUSSELS - TV5 Monde will broadcast a 90 minutes long special programme to mark the occasion of the fifth anniversary of the biggest enlargement of the EU to date. The production is realised in cooperation with the European Commission, Directorate General of Enlargement and will be broadcasted on Thursday 30th April 2009 at 9 pm (CET time).
"And the Winner is..." - Laminate Edition 1March 23rd, 2009 COESFELD, Germany - Parador's Designer Collection Receives the "Red Dot Award: Product
Design 2009"
Parador has once more produced an excellent "best practice example" of
the design success factor. On 16th March 2009, Laminate Edition 1, for which
six top international designers and architects each designed two floor
decors, won the sought-after "red dot award: product design 2009."
The "red dot award" awarded by the North Rhine Westphalia Design Centre
in Essen since 1992, enjoys worldwide acclaim as an acknowledged design
prize.
Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of DiseaseMarch 9th, 2009 EINDHOVEN, The Netherlands - The Center for Translational Molecular Medicine (CTMM) - the Dutch
public-private partnership committed to the research and development of new
techniques for the diagnosis and treatment of major diseases - today
announced that eight new research projects will receive funding from the
CTMM. It means that almost 250 million Euros have now been allocated to
Netherlands-based translational projects that could radically improve patient
outcomes for diseases such as Alzheimer's, rheumatoid arthritis, sepsis,
cardiovascular disorders and the most important forms of cancer.
Related News
Scientific system can predict H1N1 spread, claims studyJune 30th, 2009 LONDON - A scientific system, designed to rapidly evaluate the world's air traffic patterns, can accurately predict how the H1N1 virus would spread around the world, says a new study. The research has been published in the New England Journal of Medicine.
Samoa fights diseases after tsunamiOctober 5th, 2009 APIA - Samoa health officials said people who have been affected by the infectious diseases after the devastating tsunami in the island are not coming forward for treatment. Hundreds of people have been killed after a tsunami triggered by a powerful earthquake hit the South Pacific island Sep 29.
China marks 30th anniversary of diplomatic ties with TaiwanDecember 30th, 2008 BEIJING - China Wednesday commemorated the 30th anniversary of the announcement of Message to Compatriots in Taiwan that ended its military confrontation with Taipei. In the message, 30 years ago, China proposed to end the military confrontation across the Taiwan Strait through dialog and welcomed exchanges between the two sides.
NRI publisher pays tributes to Thatcher on 30th anniversary of poll winMay 8th, 2009 LONDON - A leading India-born publisher paid lavish tributes to Margaret Thatcher in the House of Commons Thursday as the former British prime minister was feted next door on the 30th anniversary of her famous election victory. 'When Margaret Thatcher won the election, Britain was called the 'sick man of Europe.' The fact that it is no longer the 'sick man' is largely due to her,' said C.B.
Face masks could protect against swine flu pandemicApril 28th, 2009 SYDNEY - Donning a face-mask is an easy way to protect oneself from severe respiratory illnesses like swine flu when vaccines are unavailable or in short supply, according to a study. In the first ever clinical trial of the efficacy of masks, researchers found adult mask wearers at home were four times more likely than non-wearers to be protected against a range of respiratory viruses, including influenza, SARS and even the common cold.
China criticises US Congress resolution on TaiwanMarch 26th, 2009 BEIJING - China has expressed strong dissatisfaction over a US Congress resolution to commemorate the 30th anniversary of the Taiwan Relations Act, saying it is an interference in its internal affairs. 'China is strongly dissatisfied and has lodged a solemn representation over the resolution adopted to commemorate the 30th anniversary of the Taiwan Relations Act,' Chinese foreign ministry spokesman Qin Gang said in a statement Wednesday.
Jeffrey Archer rewrites best selling novel 'Kane and Abel'June 15th, 2009 LONDON - After selling 34 million copies of 'Kane and Abel' in 33 different languages, author Jeffrey Archer has now rewritten his best selling novel. He did so to mark the 30th anniversary of the publication of the ultimate tale of sibling rivalry this autumn.
Scientists map epidemic trigger zonesJanuary 4th, 2009 SYDNEY - Scientists have identified and mapped potential zones that can trigger deadly outbreak of plagues and epidemics, with devastating consequences. 'A study has revealed a number of global hot-spots where new and unknown diseases are most likely to erupt - and it turns out that one of the hottest is spread in an arc to Australia's north,' warned Stephen Prowse.
Iran ready for talks with US: AhmadinejadFebruary 9th, 2009 TEHRAN - Iran's President Mahmoud Ahmadinejad said Tuesday that Iran is ready to talk in 'fair atmosphere' with the US. Ahmadinejad made the remarks in a speech marking the 30th anniversary of the victory of Iran's Islamic Revolution.
Misuse of aspirin may have made 1918 flu pandemic worseOctober 5th, 2009 WASHINGTON - Aspirin could have been responsible for the steep death toll in the 1918 flu pandemic, says a new study. High aspirin dosing levels used to treat patients during the 1918-1919 pandemic are now known to cause, in some cases, toxicity and a dangerous build up of fluid in the lungs, which may have contributed to the incidence and severity of symptoms, bacterial infections and mortality.
